scispace - formally typeset
J

Jacqueline de Belleroche

Researcher at Imperial College London

Publications -  65
Citations -  6304

Jacqueline de Belleroche is an academic researcher from Imperial College London. The author has contributed to research in topics: Amyotrophic lateral sclerosis & Heat shock protein. The author has an hindex of 34, co-authored 65 publications receiving 5608 citations. Previous affiliations of Jacqueline de Belleroche include Hammersmith Hospital & Charing Cross Hospital.

Papers
More filters
Journal ArticleDOI

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Aude Nicolas, +435 more
- 21 Mar 2018 - 
TL;DR: Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia and Charcot-Marie-Tooth type 2.
Journal ArticleDOI

Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase

TL;DR: A unique mutation in the D-amino acid oxidase gene (R199W DAO) associated with classical adult onset familial amyotrophic lateral sclerosis (FALS) in a three generational FALS kindred is reported, after candidate gene screening in a 14.52 cM region on chromosome 12q22-23 linked to disease.
Journal ArticleDOI

NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

Kevin P. Kenna, +82 more
- 25 Jul 2016 - 
TL;DR: In a new screening strategy, gene-burden analyses trained with established ALS genes are performed and a significant association between loss-of-function (LOF) NEK1 variants and FALS risk is identified.
Journal ArticleDOI

Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation.

TL;DR: It is demonstrated that the induction of COX‐2 mRNA occurs by two distinct mechanisms: the rapid and transient response to tissue damage and a second delayed and more substantial response, which is initiated by excitotoxin stimulation and is mediated by presynaptic glutamate release, NMDA receptor activation, and subsequent phospholipase A2 activity.